Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Gritstone bio, Inc. | Director | Stock Option (Right to Buy) | 51.8K | Jun 17, 2024 | Direct | ||
CytomX Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 38K | May 15, 2024 | Direct | ||
NextCure, Inc. | Director | Stock Option (Right to Buy) | 18.7K | Jun 20, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NXTC | NextCure, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
GRTS | Gritstone bio, Inc. | Jun 17, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
CTMX | CytomX Therapeutics, Inc. | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
NXTC | NextCure, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
GRTS | Gritstone bio, Inc. | Jun 16, 2023 | 1 | $0 | 4 | Jun 21, 2023 | Director |
CTMX | CytomX Therapeutics, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 16, 2023 | Director |
CTMX | CytomX Therapeutics, Inc. | Mar 29, 2023 | 1 | $7.75K | 4 | Mar 31, 2023 | Director |
NXTC | NextCure, Inc. | Jun 23, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
GRTS | Gritstone bio, Inc. | Jun 17, 2022 | 1 | $0 | 4 | Jun 22, 2022 | Director |
CTMX | CytomX Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
NXTC | NextCure, Inc. | Jun 24, 2021 | 1 | $0 | 4 | Jun 28, 2021 | Director |
GRTS | Gritstone bio, Inc. | Jun 18, 2021 | 1 | $0 | 4 | Nov 19, 2021 | Director |
CTMX | CytomX Therapeutics, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |